Symbol
|
RMAAQV | RMAAMV | RMAFCV | RMAFFV | RMBGYV | RMBKMV | RMAHIV | OTSRCH | RMAV6V | OYFRCH | OVLRCH | RMA4KV | AAYMTQ | Z0A42Z | RMA9EV | RMALYV | RMBPAV | RMAZ0V | RMBJ8V | RMASDV |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti |
Basiswert
|
Compagnie Financière Richemont SA / Galderma Group AG / Nestlé S.A. | Galderma Group AG / L'Oréal S.A. / Nestlé S.A. | Compagnie Financière Richemont SA / Galderma Group AG / Hermès International S.A. / LVMH Moet Hennessy Louis Vuitton | Alcon / Galderma Group AG / Sandoz Group AG | Alcon / Galderma Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Nestlé S.A. / Novartis AG / Roche AG | Estée Lauder Co. Inc. / Galderma Group AG / L'Oréal S.A. / Unilever N.V. | Bachem Hldg. AG / Galderma Group AG / Sandoz Group AG | Compagnie Financière Richemont SA / Galderma Group AG / Givaudan | DOCMORRIS AG / Galderma Group AG | Galderma Group AG / Roche AG / Straumann Hldg. AG | Galderma Group AG / Galenica AG / Tecan Group AG | Bachem Hldg. AG / Galderma Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG | Douglas Hldg. AG / Galderma Group AG / Unilever N.V. | Compagnie Financière Richemont SA / Galderma Group AG / Swatch Group I | CREDIT SUISSE UBS MERGER / Galderma Group AG / Sonova Hldg. AG | CREDIT SUISSE UBS MERGER / Ems-Chemie Hldg. AG / Galderma Group AG / Novartis AG | CREDIT SUISSE UBS MERGER / Galderma Group AG / Tecan Group AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG |
Emittent
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Fälligkeit
|
14.04.2025 | 14.04.2025 | 20.10.2025 | 29.06.2026 | 02.02.2026 | 16.02.2026 | 24.02.2026 | 02.03.2026 | 20.03.2026 | 30.09.2025 | 13.03.2026 | 07.04.2026 | 20.03.2026 | 09.10.2025 | 28.09.2026 | 19.10.2026 | 27.04.2026 | 12.10.2026 | 05.05.2026 | 11.05.2026 |
Geld | - | - | 80.20 | 88.00 | 90.60 | 90.10 | 63.50 | 61.33 | 90.00 | 64.46 | 83.62 | 53.00 | 66.91 | 87.41 | 57.60 | 79.30 | 61.40 | 60.70 | 58.60 | 85.90 |
Brief | - | - | 81.35 | 89.40 | 91.60 | 91.10 | - | - | 91.00 | - | 84.42 | - | - | 88.41 | - | 80.30 | - | - | - | 87.24 |